Establishing a Clinically Relevant Large Animal Model Platform for TBI Therapy Development: Using Cyclosporin A as a Case Study
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
We have developed the first immature large animal translational treatment trial of a pharmacologic intervention for traumatic brain injury (TBI) in children. The preclinical trial design includes multiple doses of the intervention in two different injury types (focal and diffuse) to bracket the range seen in clinical injury and uses two post‐TBI delays to drug administration. C yclosporin A (CsA) was used as a case study in our first implementation of the platform because of its success in multiple preclinical adult rodent TBI models and its current use in children for other indications. T ier 1 of the therapy development platform assessed the short‐term treatment efficacy after 24 h of agent administration. Positive responses to treatment were compared with injured controls using an objective effect threshold established prior to the study. Effective CsA doses were identified to study in T ier 2. In the T ier 2 paradigm, agent is administered in a porcine intensive care unit utilizing neurological monitoring and clinically relevant management strategies, and intervention efficacy is defined as improvement in longer term behavioral endpoints above untreated injured animals. In summary, this innovative large animal preclinical study design can be applied to future evaluations of other agents that promote recovery or repair after TBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524 · cited 1×
“for animal x in mg/kg equals the dose in animal y in mg/kg times (Kmy/Kmx) (70), where the estimated Km for the rat, 4-week-old piglet, human child and adult are 6, 20, 25 and 37, respectively.”
THE ROLE OF SECONDARY BRAIN INJURY IN DETERMINING OUTCOME FROM SEVERE HEAD INJURY
Chesnut, R. M., Marshall, L. F., Klauber, M. R., Blunt, B. A., Baldwin, N., Eisenberg, H. M., Jane, J. A., Marmarou, A., & Foulkes, M. A. (1993) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199302000-00006 · Cited by 2,189
Pathophysiology of traumatic brain injury
Werner, C., & Engelhard, K. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/aem131 · Cited by 1,712
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.108.541128 · Cited by 1,352 · cited 1×
“Recent workshops of the TBI and stroke scientific communities have examined why agents with preclinical therapeutic efficacy have failed to translate to clinical success (15, 27, 36, 50).”
Policy: NIH plans to enhance reproducibility
Collins, F. S., & Tabak, L. A. (2014) · Nature · doi:10.1038/505612a · Cited by 1,247
A call for transparent reporting to optimize the predictive value of preclinical research
Landis, S. C., Amara, S. G., Asadullah, K., Austin, C. P., Blumenstein, R., Bradley, E. W., Crystal, R. G., Darnell, R. B., Ferrante, R. J., Fillit, H., et al. (2012) · Nature · doi:10.1038/nature11556 · Cited by 1,196 · cited 2×
“They concluded that agents should be tested in multiple species using clinically relevant outcomes, short-term and long-term endpoints, histological and functional metrics, and include clinical management strategies (45).”
Classification of traumatic brain injury for targeted therapies
Saatman, K. E., Duhaime, A.-C., Bullock, R., Maas, A. I. R., Valadka, A., & Manley, G. T. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0586 · Cited by 1,141 · cited 2×
“The heterogeneity of TBI, with distinct pathophysiologies and mechanisms associated with contusions, hemorrhages and diffuse axonal injuries, added to a panoply of variable host factors, likely contributes to the recurrent failure of large head injury treatment trials (60, 74).”
Self-citationClinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913 · cited 1×
“The heterogeneity of TBI, with distinct pathophysiologies and mechanisms associated with contusions, hemorrhages and diffuse axonal injuries, added to a panoply of variable host factors, likely contributes to the recurrent failure of large head injury treatment trials (60, 74).”
Singh, I. N., Sullivan, P. G., Deng, Y., Mbye, L. H., & Hall, E. D. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600297 · Cited by 367
Recent advances in neurotrauma
Graham, D. I., McIntosh, T. K., Maxwell, W. L., & Nicoll, J. A. R. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.8.641 · Cited by 328
Axonal injury: a universal consequence of fatal closed head injury?
Gentleman, S. M., Roberts, G. W., Gennarelli, T. A., Maxwell, W. L., Adams, J. H., Kerr, S., & Graham, D. I. (1995) · Acta Neuropathologica · doi:10.1007/bf00571509 · Cited by 296
Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature
Schouten, J. W. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3280895d5c · Cited by 152
Combination therapies for traumatic brain injury: prospective considerations
Margulies, S. S., & Hicks, R. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008-0794 · Cited by 22
Self-citation
Cited by
The Neuropathology of Chronic Traumatic Encephalopathy
McKee, A. C., Stein, T. D., Kiernan, P. T., & Alvarez, V. E. (2015) · Brain Pathology · doi:10.1111/bpa.12248 · Cited by 585
A porcine model of traumatic brain injury via head rotational acceleration
Cullen, D. K., Harris, J. P., Browne, K. D., Wolf, J. A., Duda, J. E., Meaney, D. F., Margulies, S. S., & Smith, D. H. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-3816-2_17 · Cited by 142
Self-citationAlterations in Daytime and Nighttime Activity in Piglets after Focal and Diffuse Brain Injury
Olson, E., Badder, C., Sullivan, S., Smith, C., Propert, K., & Margulies, S. S. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4085 · Cited by 16
Self-citation
Metadata
- Authors
- Margulies, S. S., Kilbaugh, T., Sullivan, S., Smith, C., Propert, K., Byro, M., Saliga, K., Costine, B. A., & Duhaime, A.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2015-04-23
- Volume
- 25
- Issue
- 3
- Pages
- 289-303
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W2104318930
- Cited by
- 58
- References
- 13
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.